Androgen‐targeting therapeutics mitigate the adverse effect of GnRH agonist on the risk of neurodegenerative disease in men treated for prostate cancer

Androgen‐targeting therapeutics mitigate the adverse effect of GnRH agonist on the risk of neurodegenerative disease in men treated for prostate cancer

Abstract Background Prostate cancer and multiple neurodegenerative diseases (NDD) share an age‐associated pattern of onset. Therapy of prostate cancer is known to impact cognitive function. The objective of this study was to determine the impact of multiple classes of androgen‐targeting therapeutics...

Full description

Bibliographic Details
Main Authors: Gregory L. Branigan, Georgina Torrandell‐Haro, Maira Soto, Edward P. Gelmann, Francesca Vitali, Kathleen E. Rodgers, Roberta Diaz Brinton
Format: Article
Language:English
Published: Wiley 2022-07-01
Series:Cancer Medicine
Subjects:
abiraterone
Alzheimer's disease
androgen
medical informatics
neurodegenerative disease
prostate cancer
Online Access:https://doi.org/10.1002/cam4.4650

Similar Items

Similar Items